JMJD6 and mesothelioma: High levels of JMJD6 significantly reduced DFS in patients with KIRP, LUSC, and uveal melanoma (UVM), as well as OS in patients with KIRC and mesothelioma (MESO) (Figures 2B, C), suggesting the carcinogenic effect of JMJD6 in these tumors.